Navigation Links
Herbruck Alder Survey Reveals More Northern Ohio Companies Offering Employee Wellness Programs
Date:2/3/2010

CLEVELAND, Feb. 3 /PRNewswire/ -- Twenty three percent of Northern Ohio employers responding to a recent survey by Herbruck Alder, a Cleveland-based employee benefits firm, acknowledge that they have comprehensive wellness programs.  This is an increase of seven percent over the results of the previous annual survey.

According to Herbruck Alder's Third Annual Employer Wellness Survey, another 17 percent of respondents are in the process of developing a wellness program.  

Respondents – primarily human resources administrators -- noted that the leading perceived employee health risks are high blood pressure, smoking, and obesity  

"As medical costs continue to outpace inflation, employers are searching for effective cost-reduction strategies," says Mark Alder, president of Herbruck Alder.  "That is why programs focused on biometric screening and employee lifestyle choices are quickly becoming a key component to many employer strategies."  

Some 164 employers – private companies, non-profits, and government districts ranging from 25 to more than 2,000 employees -- completed the online survey. The results also identified best practices in wellness programs, as well as their financial advantage.  

Other findings:

  • 51 percent offer smoking cessation programs through health plans.

  • 45 percent offer weight control and/or weight loss services.

  • 80 percent offer onsite food services, from full-service cafeterias to vending machines. Of those, 34 percent publish nutritional content to help employees make healthy food choices.

  • 39 percent can identify successes within their wellness programs, such as employees quitting smoking, sharing healthy recipes, starting exercise programs, and participating in weight-loss competitions.

The benefits aside, the survey also reveals that 61 percent of the companies without a wellness program do not intend to make changes because of budget constraints.

"Yet in the long run a wellness program can reduce healthcare costs," notes Alder. "In fact, studies have proven that 70 percent of every dollar spent on healthcare in the U.S. is directly attributed to the lifestyle of the patient."

The survey results will be presented at a breakfast on Thursday, February 11, from 8:30-10:30a.m. at the Hilton Garden Inn, 1100 Carnegie Avenue, in downtown Cleveland. Panelists include worksite wellness experts from, COSE, the Cleveland Museum of Natural History, Be Well Solutions, and Walter & Haverfield LLP. 

For presentation reservations and information about the survey, contact Alison Muth at 216.623.2600 or amuth@herbruckalder.com. For more information about Herbruck Alder, visit www.herbruckalder.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Mark Alder

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=93381

SOURCE Herbruck Alder

RELATED LINKS
http://www.herbruckalder.com

'/>"/>

SOURCE Herbruck Alder
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Herbruck Alder to Convene Summit: Coming Together to Explain Healthcare Legislation
2. After 31 Years, the New San Jose Caldera Highway is Now Fully Operational in Costa Rica
3. The Beryl Companies Hires Jim Stalder as New Chief Information Officer
4. Wilmer Valderrama to Co-Host Cielo Latino with Miss Universe Dayana Mendoza
5. Galderma Launches New Cetaphil(R) SPF 50 Product
6. Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
7. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
8. Galderma announces approval for Differin gel 0.1 percent in Japan
9. Galderma Completes Tender Offer for CollaGenex
10. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
11. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... , ... "I have gout, and I wanted to treat it naturally," said ... to relieve gout and pain caused by varicose veins. I drank it every morning ... relieved what VA doctors called the worst sinusitis case they'd seen and relieved gas, ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric ... patient safety. Only a few hospitals and facilities have earned this distinction. This ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the ... and Eric Hoessel to vice president of sales. , Litsinger joined Mirixa ...
(Date:12/8/2016)... ... 08, 2016 , ... SunView Software aims to redefine IT ... both engaging and easy to use. Coming off the heels of a successful ... its plans to roll out new AI-powered self-service enhancements to help organizations implement ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 9, 2016 Research and Markets has ... report to their offering. ... The report forecasts the global optical transceiver market ... The report covers the present scenario and the ... calculate the market size, the report considers the revenue generated from ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company ... severe, rare diseases, today announced that senior management will participate in ... Conference at the InterContinental Barclay Hotel in New York ... ET. About aTyr Pharma ... aTyr Pharma is engaged in the ...
(Date:12/9/2016)... Bermuda , Dec. 9, 2016  Axovant ... leading clinical-stage biopharmaceutical company focused on the treatment ... the data from a Phase 2b trial evaluating ... care donepezil, compared with donepezil plus placebo in ... that the addition of intepirdine to treatment was ...
Breaking Medicine Technology: